MD

Mayur Dhirajlal Ramani

Active Director Designated Partner DIN 10745379
DIN 10745379 First appointment Aug 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mayur Dhirajlal Ramani

Data last updated:

Mayur Dhirajlal Ramani is a Designated Partner at Fenvitta Life Sciences Llp (since 2024).

DIN 10745379
Primary Designation Designated Partner
First Appointment 16 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 Aug 20242024Active

Board colleagues of Mayur Dhirajlal Ramani

NameDINCompanyDesignation
Himanshu Manharlal Jogiya10745380Fenvitta Life Sciences LlpDesignated Partner
Pravin Nathabhai Bhanderi10250847Fenvitta Life Sciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Fenvitta Life Sciences Llp
Premium access

Shareholding and investment profile for Mayur Dhirajlal Ramani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mayur Dhirajlal Ramani

Mayur Dhirajlal Ramani currently holds 1 directorship: Fenvitta Life Sciences Llp (Designated Partner, since 16 Aug 2024).

Mayur Dhirajlal Ramani was first appointed on 16 Aug 2024 as Designated Partner at Fenvitta Life Sciences Llp.

The current boards of Mayur Dhirajlal Ramani's companies include Himanshu Manharlal Jogiya (Fenvitta Life Sciences Llp), Pravin Nathabhai Bhanderi (Fenvitta Life Sciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available